A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCON

NCT03918447 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

667

Enrollment

INDUSTRY

Sponsor class

Stopped Discontinuation of all bardoxolone chronic kidney disease programs

Conditions

Autosomal Dominant Polycystic Kidney
ADPKD

Interventions

DRUG: Bardoxolone methyl oral capsule
DRUG: Placebo oral capsule

Sponsor

Biogen